US Worldmeds LLC

FDA Regulatory Profile

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-1275-2019Class IIRevonto (dantrolene sodium for injection), 20 mg/vial, For treatment of malignant hyperthermia, For April 25, 2019